TCG Crossover Management »

Urogen Pharma shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 717k 19.95

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma